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Abstract
Introduction: Primary rectal lymphoma is a rare disease. In this paper we present an unusual case
of primary rectal lymphoma which was managed with chemotherapy and discussed by a thorough
review of the related literature.
Cases presentation: An 85-years-male patient was diagnosed in Sidi Mohammed Ben Abdellah
Hospital as having diffuse large B-cell lymphoma of the rectum at a bulky stage two. This patient
was managed successfully with 8 treatment cycles of Cyclophosphamide 750 mg/m2 at day 1 of each
cycle, Doxorubicin (50 mg/m2 in the first 4 cycles and 25 mg/m2 in the subsequent cycles) at day
1 of each cycle, Vincristine 1.4 mg/m2 at day 1 of each cycle, and prednisone 50 mg/m2 at day 1 to
5 of each cycle.
Conclusion: The optimal treatment of primary rectal lymphoma needs more research studying to
be achieved.
Introduction
Lymphomas are malignant neoplasms of the lymphocyte
cell lines. They mainly involve lymph nodes, spleen and
other non-haemopoietic tissues. They are mainly classi-
fied as either Hodgkin's or non-Hodgkin's lymphomas
(NHL), and of either B-lymphocyte or T-lymphocyte ori-
gin. According to estimates, in 2008, 66120 new cases of
NHL occurred in United State. Gastrointestinal NHL
account for 4% to 20% of all NHL. Approximately 0.2 to
0.6% of malignant lymphomas arise in the colorectal tract
[1]. Primary rectal NHL is rare accounting for 0.2% of all
rectal malignancies [2]. The diffuse large B-cell lymphoma
(DLBCL) is the most common type of primary colorectal
non Hodgkin lymphoma (NHL) [1]. In this paper, we will
present a case of primary rectal diffuse large B-cell lym-
phoma at bulky stage II in an 85 year old man with unu-
sual presentation and focus on the role of chemotherapy
according to the English literature.
Case presentation
A 85-years-old Morrocan Arab man was admitted to the
National Institute of Oncology Hospital with alteration of
health (asthenia without weight loss), systemic symptoms
(Fever, shudder, profuse sweat), yellow rectal secretions
for 18 months, and enlarged tumour in the peri-anal
region and rectal tenesmus for 3 months. The tumour
mass increased rapidly in volume and was associated with
ulceration at the surface. The patient suffered equally of
urinary signs of dysuria and pollakiuria. The evolution
was marked by the apparition of inguinal lymph nods 3
months ago. His past medical history did not include co-
morbidities, polypharmacy, malnutrition or dependency.
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At presentation, the patient had an ECOG performance
status equal to 2.0. Physical examination of the pelvis
showed a heavily peri-anal ulcerative-vegetative mass
measuring 10 × 10 × 4 cm (Figure 1). The examination of
ganglionic aereas showed bilateral lymph nodes in the
inguinal region measuring 2 × 2 cm (Figure 2). Pelvic
computed tomography scan showed a circumferential
anorectal tissular process associated with retro rectal and
bilateral inguinal lymph nodes. The tumour infiltrated the
mesorectal fate, provoked a thickness of the fascias and
came in contact with obturator muscles (Figure 3 and 4).
The rectal biopsy was performed. Histological and immu-
nohistochemistry studies showed DLBCL of the rectum
according to the Revised European-American Classifica-
tion of Lymphoid Neoplasms/World Health Organisation
classification of lymphoid neoplasms (REAL/WHO).
Most of the neoplasic cells were positive for CD-20 and
for leukocyte common antigen (LCA) antibody. Com-
puted tomography of the chest and abdomen was normal.
The erythrocyte sedimentation rate was increased to 70
mm in the first hour. The white blood cell counts were
within normal limits. A bone marrow biopsy showed no
abnormalities. The patient was staged IIEXBb according to
the Ann Arbor Staging system. Before first chemotherapy
cycle, the cardiac fraction ejection was normal and was
equal to 75%. The patient received 8 cycles of Cyclophos-
phamide 750 mg/m2 d1, Doxorubicin (50 mg/m2 in the
first 4 cycles and 25 mg/m2 in the subsequent cycles) d1,
Vincristine 1.4 mg/m2 d1, and prednisone 50 mg/m2 d1-5
(CHOP) regimen with good tolerance. He achieved com-
plete clinical and radiological response and remained dis-
ease free 12 months after the end of chemotherapy
treatment (Figure 5).
Discussion
The maximum incidence of colorectal lymphomas is in
the 50 to 70 year age group. The mean age at diagnosis
was between 50 and 55 (3-83) years [3].
The standard criteria for the diagnosis of primary intesti-
nal lymphomas were established by Dawson et al [4].
Peri-anal ulcerative-vegetative tumour measured 10 × 10 × 4  cm Figure 1
Peri-anal ulcerative-vegetative tumour measured 10 
× 10 × 4 cm.
Enlarged lymph nodes in the inguinal area (see arrow) Figure 2
Enlarged lymph nodes in the inguinal area (see 
arrow).
Pelvic computed tomography scan performed before chemo- therapy treatment shows the Bulky anorectal process (see  arrows) Figure 3
Pelvic computed tomography scan performed before 
chemotherapy treatment shows the Bulky anorectal 
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Tumours were considered to be primary on the following
grounds: 1. The patient at first dose not present palpable
superficial lymphadenopathy; 2. Chest radiographs
showed no obvious enlargement of the mediastinal
nodes; 3. The white blood cell counts, total and differen-
tial, were within normal limits; 4. At laparotomy the
bowel lesion predominated, the only lymph nodes, obvi-
ously affected, are those in its immediate neighbourhood;
5. The liver and spleen appeared free of tumour in every
case. Normal bone marrow biopsy examination and the
absence of lymphadenopathy on computed tomographic
(CT) scan of the mediastinun should be added to these
criteria [3]. In the present case, the patient presented ini-
tially a heavily anorectal tumour followed by the involve-
ment of the inguinal lymph nodes, which constitute the
first lymphatic drainage of anal margin, without other
radiological abnormalities. Tumour therefore fulfilled
Dawson et al and Richards's criteria for primary colonic
lymphoma.
The B cell lymphoma constitutes 85% of all primary
colorectal lymphomas, with T cell lymphoma accounting
for the remainder (15%). The differentiation between
both lymphomas is done by the use of a cluser of differen-
tiation antibodies (CD). The CD2, CD3, CD4, CD7 and
CD8 are used to determine the T cell lymphoma. The
CD20, CD79a, and CD10 are used to determine the B cell
lymphoma [5]. The most common histological types of
primary colorectal lymphomas, following the Revised
European-American Classification of Lymphoid Neo-
plasms/World Health Organisation classification of lym-
phoid neoplasms (REAL/WHO), are: diffuse large B-cell
lymphoma, Mantle-cell lymphoma and Burkitt's lym-
phoma [1]. In the case of our patient, most of the neopla-
sic cells were positive for CD-20 and for LCA antibody.
Because primary rectal lymphoma is rare, the optimal
treatment for this disease remains to be more standard-
ized. However, the role of surgery in the management of
primary colorectal lymphoma is well defined. Surgical
resection is the only statistically significant prognostic for
patients with intestinal lymphomas [6]. It was reported
that debulking surgery improves overall survival (OS) and
disease free survival (DFS) [7]. In addition, 5-year survival
rates were 46% for patients who underwent surgery vs 0%
for patients managed without surgery [8]. The value of
chemotherapy in case of intestinal lymphomas is less
defined. In one series of colorectal lymphoma, all authors
concluded that the surgery should be the primary treat-
ment for localised disease; Chemotherapy and radiother-
apy must be considered for advanced disease and for
malignant lymphomatous poliposis [9]. Other authors
showed a significant improvement in survival time (47.9
months vs 117.4 months) in patients with stage II high-
grade colorectal lymphomas receiving adjuvant chemo-
therapy [10]. In another series, adjuvant chemotherapy
after complete resection of colonic lymphoma improved
significantly the disease free survival [11]. No series to
date has reported experience with chemotherapy or radio-
therapy as initial therapy for colonoscopically defined,
surgically resectable primary colorectal lymphomas [12].
Pelvic computed tomography scan performed before chemo- therapy treatment shows the Bulky anorectal process with  enlarged lymph nodes in the inguinal areas (see arrows) Figure 4
Pelvic computed tomography scan performed before 
chemotherapy treatment shows the Bulky anorectal 
process with enlarged lymph nodes in the inguinal 
areas (see arrows).
Pelvic computed tomography scan performed after the end  of chemotherapy shows complete radiological response of  the ano-rectal tumour Figure 5
Pelvic computed tomography scan performed after 
the end of chemotherapy shows complete radiologi-
cal response of the ano-rectal tumour.Cases Journal 2009, 2:9373 http://www.casesjournal.com/content/2/1/9373
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Although, the management of large bowel lymphoma
involves a combination of surgery and chemotherapy, pri-
mary lymphoma of the rectum should be considered as a
different clinico-pathological entity and treatment for this
disease should be defined based on this special clinical
condition. The value of surgery for primary lymphoma of
the rectum is uncertain. In a review of 12 cases with lym-
phoma confined to the rectum (stage IE) reported by
Mayo Clinic Centre, 5 patients undergone radical surgical
resection and 7 patient received non surgical treatment.
The authors showed that patients who had surgical exci-
sion did better than those treated nonoperatively [13].
Other authors confirmed the efficacy of surgery alone or
in combination with radiotherapy or chemotherapy
(Table 1). There have been rare cases managed with chem-
otherapy with or without radiotherapy (Table 1). Radio-
therapy should be considered in mono therapy for the
management of stage IE MALT (mucosa-associated lym-
phoid tissue) lymphoma and in combination with cyto-
toxic chemotherapy for the management of stage IE
DLBCL (Table 1). Eradication of helicobacter pilory has
also been used as an effective treatment of stage IE MALT
lymphoma (Table 1).
For patients with widespread diseases the chemotherapy
should be considered as logical treatment for colorectal
lymphomas. The most widely chemotherapy used was
CHOP (Cyclophosphamide 750 mg/m2 day 1, Doxorubi-
cine 50 mg/m2 day 1, Vincristine 1.4 mg/m2 day 1, and
prednisone 50 mg/m2 day 1 to 5) regimen [12]. Our
patient with bulky disease was managed exclusively with
CHOP chemotherapy with complete clinical and radio-
logical response.
Using combined surgery and adjuvant chemotherapy, 5-
year survival rates of patients with colorectal lymphoma
have ranged from 27% to 55% [12].
Conclusion
Lymphomas of the rectum should be considered as a dif-
ferent clinico-pathological entity. According to the litera-
ture, DLBCL of the large bowel must be treated with
aggressive surgery followed by adjuvant chemotherapy.
Although it is not possible to make a legitimate conclu-
sion with a single case, we highlight the important role of
chemotherapy for achieving successful treatment cure for
patients with rectal DLBCL at stage IIEX. For this reason,
the optimal treatment of this disease remains to be
defined.
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Table 1: Clinical and pathological findings and outcome of selected published cases with stage IE primary NHL of the rectum managed 
with different strategies
Author Year Age (years) Sex Histological diagnosis Stage Treatment Response Follow-up Status
Unal [5] 2008 43 Female DLBCL IE CT → RT CR 43 NED
Amouri [14] 2008 46 Female MALT IE RT CR 12 NED
Foo [15] 2008 60 Male MALT IE RT CR 41 NED
Guney [16] 2007 67 Female DLBCL IE CT → RT CR 12 NED
Wong [12] 2005 65 Male Mantle IE S CR 36 NED
Bilsel [17] 2004 33 Male DLBCL IE CT → RT CR 36 NED
Navarra [18] 2003 - - MALT IE S → CT CR 36 NED
Matsumoto [19] 1997 - - MALT IE EHP CR 3 NED
Shimono [20] 1995 58 Female DLBCL IE RT+HT → SC R 6 0 N E DPublish with BioMed Central    and   every 
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